文献速递运动医学关节外科

ICRS损伤分级对内侧半月板同种异体移植术后移植物存活的影响:基于MRI的客观评估

Effect of ICRS Lesion Grade on Graft Survival After Medial Meniscal Allograft Transplantation: MRI-Based Objective Evaluation.
PubMed 文献 · Am J Sports Med · 2022-10-05

该病例对照研究回顾了1996年至2018年间78例初次内侧半月板同种异体移植患者,随访平均6.9±5.3年,评估移植物解剖存活率和临床存活率及其预后因素。结果显示10年解剖存活率为73.89%、临床存活率为87.90%,仅高级别ICRS损伤(3或4级)与解剖存活显著相关(HR 3.171)。低级别ICRS损伤患者10年解剖存活率高于高级别者(87.6% vs 63.3%,P=0.022)。

要点

  • 高级别ICRS损伤(3或4级)与内侧半月板移植术后解剖失败风险升高相关(HR 3.171,95%CI 1.124-8.944,P=0.029)。
  • 低级别ICRS损伤(0、1或2级)患者10年解剖存活率87.6%,高于高级别者的63.3%(P=0.022)。
  • 高级别ICRS损伤患者临床结局可能良好,但移植物状态可能较差,术者应告知患者需密切观察。

核心结论

  • 低级别ICRS损伤与内侧半月板同种异体移植术后更高的解剖存活率相关。
  • 高级别ICRS损伤患者临床结局可能良好,但移植物状态可能较差;术者应告知患者需密切观察。

研究设计与样本

  • 病例对照研究,证据等级3级。
  • 回顾了1996年至2018年间78例连续接受初次内侧半月板同种异体移植患者的记录。
  • 采用Kaplan-Meier生存分析评估解剖存活率和临床存活率。
  • 解剖失败定义为撕裂覆盖超过50%的同种异体移植物或边缘不稳定;临床失败定义为Lysholm评分低于65分或需额外手术(如半月板修复、翻修移植、力线截骨、切除超过50%移植物的半月板切除)。
  • 分析了影响解剖失败和临床失败的患者因素。

主要发现

  • 平均随访时间6.9±5.3年(范围2-21年)。
  • 解剖失败19例(24.4%),其中无患者持续Lysholm评分低于65分;这19例中2例接受半月板修复的患者同时出现临床失败。
  • 临床失败7例(9.0%):4例Lysholm评分低于65分,2例接受半月板修复,1例接受力线截骨。
  • 估计10年解剖存活率为73.89%,临床存活率为87.90%。
  • 解剖存活仅与高级别ICRS损伤(3或4级)显著相关(HR 3.171,95%CI 1.124-8.944,P=0.029);临床存活率与任何因素均无显著关联。

关键数值与推荐

  • 高级别ICRS损伤(3或4级)与解剖失败的HR为3.171(95%CI 1.124-8.944,P=0.029)。
  • 低级别ICRS损伤(0、1或2级)患者10年解剖存活率87.6%,高级别ICRS损伤患者为63.3%(P=0.022)。
  • 估计10年解剖存活率73.89%,临床存活率87.90%。
  • 解剖失败19例(24.4%),临床失败7例(9.0%)。

临床怎么用

  • 作者认为,对于高级别ICRS损伤患者,临床结局可能良好,但移植物状态可能较差。
  • 作者建议,术者应意识到这一点,并向患者说明需要密切观察。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data are lacking regarding the survival rate after medial meniscal allograft transplantation (MAT) alone. Furthermore, little information is available about prognostic factors for graft survival that affect the outcomes of medial MAT. PURPOSE: To investigate the prognostic factors and survival rate of allograft after medial MAT. STUDY DESIGN: Case-control study; Level of evidence, 3. METHODS: The records of 78 consecutive patients who underwent primary medial MAT between 1996 and 2018 were reviewed. Kaplan-Meier survival analysis was performed to analyze the anatomic and clinical survival rates. Anatomic failure was defined as a tear covering >50% of the allograft or unstable peripheral rim. Clinical failure was considered Lysholm score <65 or need for additional surgery such as meniscal repair, revision MAT, realignment osteotomy, and meniscectomy for >50% of the allograft. Patient factors affecting anatomic and clinical failure were analyzed. RESULTS: The mean follow-up period was 6.9 ± 5.3 years (range, 2-21 years). Anatomic failure was noted in 19 patients (24.4%), and none of these patients had a persistent poor Lysholm score of <65; of these, 2 patients who underwent meniscal repair also had clinical failure. Clinical failure was noted in 7 patients (9.0%); 4 patients had Lysholm score <65, 2 patients underwent meniscal repair, and 1 patient underwent realignment osteotomy. The estimated 10-year anatomic and clinical survival rates were 73.89% and 87.90%, respectively. Anatomic survival was significantly associated with only high-grade International Cartilage Regeneration & Joint Preservation (ICRS) lesion (ICRS grade 3 or 4) (hazard ratio, 3.171; 95% CI, 1.124-8.944; P = .029). However, the clinical survival rate was not significantly associated with any factors. Patients with low-grade ICRS lesion (ICRS grade 0, 1, or 2) showed a higher estimated 10-year anatomic survival rate compared with patients with high-grade ICRS lesions (87.6% vs 63.3%, respectively; P = .022). CONCLUSION: Low-grade ICRS lesion was associated with higher anatomic survival rate after medial MAT. In patients with high-grade ICRS lesions, the clinical outcome might be good; however, the status of an allograft might be poor. The surgeon should be aware of this and explain to the patient that close observation is necessary.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Lee SJ, Bin SI, Kim JM, et al. Effect of ICRS Lesion Grade on Graft Survival After Medial Meniscal Allograft Transplantation: MRI-Based Objective Evaluation. Am J Sports Med. 2022. PMID: 36197080. doi:10.1177/03635465221124897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。